BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4006474)

  • 21. Hemodynamic long-term effects of hemofiltration on dialysis and drug-resistant hypertension.
    Jahn H; Schohn D; Gullberg C; Schmitt R
    Contrib Nephrol; 1982; 32():61-8. PubMed ID: 7128164
    [No Abstract]   [Full Text] [Related]  

  • 22. Echocardiographic hemodynamic study during ultrafiltration sequential dialysis.
    Cini G; Camici M; Pentimone F; Palla R
    Nephron; 1982; 30(2):124-30. PubMed ID: 7099320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical tolerance test of a new polysulfone membrane.
    Piazolo P; Brech W
    Contrib Nephrol; 1985; 46():118-26. PubMed ID: 3891223
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective anticoagulation by a low molecular weight heparin (Fragmin) in hemodialysis with a highly permeable polysulfone membrane.
    Ljungberg B; Jacobson SH; Lins LE; Pejler G
    Clin Nephrol; 1992 Aug; 38(2):97-100. PubMed ID: 1325310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thermal energy balance during hemodialysis: the role of the filter membrane].
    Panzetta G; Bianco F; Galli G; Ianche M; Savoldi S; Vianello S; Vidi E; Cicinato P
    G Ital Nefrol; 2002; 19(4):425-31. PubMed ID: 12369045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemodiafiltration using a polysulfone membrane, its ultrafiltration characteristics and biocompatibility].
    Iarmolinskiĭ IS; Stetsiuk EA; Iarmagomedov AA
    Urol Nefrol (Mosk); 1987; (2):45-9. PubMed ID: 3590419
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study.
    Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL; Vincent JL; Tielemans C
    Nephrol Dial Transplant; 2000 Feb; 15(2):224-30. PubMed ID: 10648669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colchicine clearance by high-flux polysulfone dialyzers.
    Ben-Chetrit E; Backenroth R; Levy M
    Arthritis Rheum; 1998 Apr; 41(4):749-50. PubMed ID: 9550491
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of hemodialysis membranes on serum albumin.
    Locatelli F;
    Am J Kidney Dis; 2001 Feb; 37(2):455-6. PubMed ID: 11157397
    [No Abstract]   [Full Text] [Related]  

  • 32. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
    Smeby LC; Widerøe TE; Balstad T; Jørstad S
    Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets].
    Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I
    Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease in serum pentosidine levels of ESRD patients during polysulfone haemodialysis.
    Stein G; Franke S; Sperschneider H; Vienken J; Ueda Y; Miyata T; Kurokawa K
    Nephrol Dial Transplant; 1999 Jun; 14(6):1606-8. PubMed ID: 10383042
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemodynamic and atrial natriuretic peptide responses to fluid removal and reinfusion in hemodialysis patients.
    Petersen J; Li CC; Bishop-Abney N; Seniw CM
    ASAIO Trans; 1988; 34(3):509-11. PubMed ID: 2973791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of the new, steam-sterilized polysulfone high-flux dialyzer.
    Schaefer RM; Kulzer P; Gilge U; Schaefer L; Heidland A
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S21-5. PubMed ID: 7923978
    [No Abstract]   [Full Text] [Related]  

  • 37. A randomized, controlled study of the consequences of hemodialysis membrane composition on erythropoietic response.
    Richardson D; Lindley EJ; Bartlett C; Will EJ
    Am J Kidney Dis; 2003 Sep; 42(3):551-60. PubMed ID: 12955684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of cellulose triacetate and polysulfone membrane on GPIIb/IIIa and platelet activation.
    Kuragano T; Kuno T; Takahashi Y; Yamamoto C; Nagura Y; Takahashi S; Kanmatsuse K
    Blood Purif; 2003; 21(2):176-82. PubMed ID: 12601261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of blood volume-controlled ultrafiltration on hemodynamic stability and quality of life.
    Sentveld B; van den Brink M; Brulez HF; Potter van Loon BJ; Weijmer MC; Siegert CE
    Hemodial Int; 2008 Jan; 12(1):39-44. PubMed ID: 18271839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.